Schering Claritin Awaits FDA Certification; Correctol SKUs To Be Discontinued
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough's first batch of products submitted to FDA for certification under a May 16 consent decree will include the Claritin 10 mg dose
You may also be interested in...
GSK Consent Decree Includes $650 Mil. Bond, Third-Party Inspections
GlaxoSmithKline appears to have negotiated a more favorable consent decree agreement with FDA compared to previous pharmaceutical companies facing similar action
GSK Consent Decree Includes $650 Mil. Bond, Third-Party Inspections
GlaxoSmithKline appears to have negotiated a more favorable consent decree agreement with FDA compared to previous pharmaceutical companies facing similar action
GSK Consent Decree Includes $650 Mil. Bond, Third-Party Inspections
GlaxoSmithKline appears to have negotiated a more favorable consent decree agreement with FDA compared to previous pharmaceutical companies facing similar action